Maravai LifeSciences Holdings Inc banner

Maravai LifeSciences Holdings Inc
NASDAQ:MRVI

Watchlist Manager
Maravai LifeSciences Holdings Inc Logo
Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
Watchlist
Price: 3.15 USD 2.27% Market Closed
Market Cap: $809.8m

Wall Street
Price Targets

MRVI Price Targets Summary
Maravai LifeSciences Holdings Inc

Wall Street analysts forecast MRVI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MRVI is 4.01 USD with a low forecast of 2.02 USD and a high forecast of 5.25 USD.

Lowest
Price Target
2.02 USD
36% Downside
Average
Price Target
4.01 USD
27% Upside
Highest
Price Target
5.25 USD
67% Upside
Maravai LifeSciences Holdings Inc Competitors:
Price Targets
GLSI
Greenwich Lifesciences Inc
72% Upside
BWXT
BWX Technologies Inc
12% Upside
0IF
LogicBio Therapeutics Inc
68% Upside

Revenue
Forecast

4% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
4% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

For the last 6 years the compound annual growth rate for Maravai LifeSciences Holdings Inc's revenue is 4%. The projected CAGR for the next 3 years is 9%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-19%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-19%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MRVI's stock price target?
Price Target
4.01 USD

According to Wall Street analysts, the average 1-year price target for MRVI is 4.01 USD with a low forecast of 2.02 USD and a high forecast of 5.25 USD.

What is Maravai LifeSciences Holdings Inc's Revenue forecast?
Projected CAGR
9%

For the last 6 years the compound annual growth rate for Maravai LifeSciences Holdings Inc's revenue is 4%. The projected CAGR for the next 3 years is 9%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett